使用血清素 7 型受体拮抗剂对慢性压力进行药理干预。动物研究的启示

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Marcin Siwiec , Grzegorz Hess
{"title":"使用血清素 7 型受体拮抗剂对慢性压力进行药理干预。动物研究的启示","authors":"Marcin Siwiec ,&nbsp;Grzegorz Hess","doi":"10.1016/j.biocel.2024.106647","DOIUrl":null,"url":null,"abstract":"<div><p>This mini-review presents our current understanding of serotonin type 7 receptor research focusing on the possible network mechanisms underlying the behavioral action of receptor antagonists. The serotonin type 7 receptor is expressed widely throughout the nervous system and known to be involved in various cognitive and physiological mechanisms. It became a clinically significant target after the discovery that its selective antagonist SB 269970 can exert rapid-onset antidepressant effects either alone or in combination with lower doses of conventional antidepressant drugs. Further research has shown that administration of SB 269970 can effectively counteract negative neurobiological outcomes in various chronic stress paradigms. The authors hope they can introduce a wider scientific audience to this promising pharmacological target which, if successful, could in time lead to more discoveries and a better understanding of the underlying serotonin receptor biology as well as its clinical potential.</p></div><div><h3>Highlights</h3><p></p><ul><li><span>•</span><span><p>The 5-HT<sub>7</sub> receptor is widely distributed throughout the nervous system.</p></span></li><li><span>•</span><span><p>5-HT<sub>7</sub> receptor antagonist SB 269970 exerts rapid-onset antidepressant effects.</p></span></li><li><span>•</span><span><p>Antidepressant effects of SB 269970 occur via changes in dorsal raphe activity and subsequent cortical serotonin release.</p></span></li></ul></div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1357272524001390/pdfft?md5=0817d2acbde2c687b28f881a070b51ec&pid=1-s2.0-S1357272524001390-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The use of serotonin type 7 receptor antagonists as a pharmacological intervention in chronic stress. Insights from animal studies\",\"authors\":\"Marcin Siwiec ,&nbsp;Grzegorz Hess\",\"doi\":\"10.1016/j.biocel.2024.106647\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This mini-review presents our current understanding of serotonin type 7 receptor research focusing on the possible network mechanisms underlying the behavioral action of receptor antagonists. The serotonin type 7 receptor is expressed widely throughout the nervous system and known to be involved in various cognitive and physiological mechanisms. It became a clinically significant target after the discovery that its selective antagonist SB 269970 can exert rapid-onset antidepressant effects either alone or in combination with lower doses of conventional antidepressant drugs. Further research has shown that administration of SB 269970 can effectively counteract negative neurobiological outcomes in various chronic stress paradigms. The authors hope they can introduce a wider scientific audience to this promising pharmacological target which, if successful, could in time lead to more discoveries and a better understanding of the underlying serotonin receptor biology as well as its clinical potential.</p></div><div><h3>Highlights</h3><p></p><ul><li><span>•</span><span><p>The 5-HT<sub>7</sub> receptor is widely distributed throughout the nervous system.</p></span></li><li><span>•</span><span><p>5-HT<sub>7</sub> receptor antagonist SB 269970 exerts rapid-onset antidepressant effects.</p></span></li><li><span>•</span><span><p>Antidepressant effects of SB 269970 occur via changes in dorsal raphe activity and subsequent cortical serotonin release.</p></span></li></ul></div>\",\"PeriodicalId\":3,\"journal\":{\"name\":\"ACS Applied Electronic Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1357272524001390/pdfft?md5=0817d2acbde2c687b28f881a070b51ec&pid=1-s2.0-S1357272524001390-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Electronic Materials\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1357272524001390\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, ELECTRICAL & ELECTRONIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1357272524001390","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

摘要

这篇微型综述介绍了我们目前对血清素 7 型受体研究的理解,重点是受体拮抗剂行为作用的可能网络机制。血清素 7 型受体在整个神经系统中广泛表达,已知参与了各种认知和生理机制。在发现其选择性拮抗剂 SB 269970 可单独或与较低剂量的传统抗抑郁药物联用产生快速起效的抗抑郁效果后,它成为了一个具有临床意义的靶点。进一步的研究表明,在各种慢性应激范例中,服用 SB 269970 可以有效抵消负面的神经生物学结果。作者希望他们能向更多的科学界人士介绍这一前景广阔的药理学靶点,如果成功的话,将能及时带来更多的发现,让人们更好地了解潜在的血清素受体生物学及其临床潜力。关键点:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The use of serotonin type 7 receptor antagonists as a pharmacological intervention in chronic stress. Insights from animal studies

This mini-review presents our current understanding of serotonin type 7 receptor research focusing on the possible network mechanisms underlying the behavioral action of receptor antagonists. The serotonin type 7 receptor is expressed widely throughout the nervous system and known to be involved in various cognitive and physiological mechanisms. It became a clinically significant target after the discovery that its selective antagonist SB 269970 can exert rapid-onset antidepressant effects either alone or in combination with lower doses of conventional antidepressant drugs. Further research has shown that administration of SB 269970 can effectively counteract negative neurobiological outcomes in various chronic stress paradigms. The authors hope they can introduce a wider scientific audience to this promising pharmacological target which, if successful, could in time lead to more discoveries and a better understanding of the underlying serotonin receptor biology as well as its clinical potential.

Highlights

  • The 5-HT7 receptor is widely distributed throughout the nervous system.

  • 5-HT7 receptor antagonist SB 269970 exerts rapid-onset antidepressant effects.

  • Antidepressant effects of SB 269970 occur via changes in dorsal raphe activity and subsequent cortical serotonin release.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信